ArticleCancer science2019
CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells.
Ariunbold Natsagdorj et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
45 papers cite it
this papercites it